Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Raymond Harris, Jr, MD

Professor of Medicine

Division of Nephrology and Hypertension

Ann and Roscoe R. Robinson Chair in Nephrology

Associate Director, Division of Nephrology and Hypertension

Raymond Harris, Jr
Professional Bio
Raymond Harris, MD, is the Ann Roscoe Robinson Professor of Medicine and Associate Chief of the Division of Nephrology and Hypertension and Director of the Vanderbilt Center for Kidney Disease (VCKD). He has a longstanding interest in understanding mechanisms and developing potential therapeutic interventions for acute and chronic renal injury. His research has focused on the role of growth factors, and especially the EGF family of growth factors, in mediating the recovery from acute kidney injury and as potential mediators of progressive fibrosis in chronic kidney disease (CKD). His research group investigates the role of the innate immune system in acute kidney infection (AKI) and in subsequent development of CKD. He also has a longstanding interest in underlying mechanisms of progressive kidney injury and especially in diabetic nephropathy. He also studies kidney physiology and pathophysiology and especially in the role of eicosanoids in in the kidney and specifically in defining important physiologic and pathophysiologic roles of cyclooxygenase-2 metabolites in the kidney in regulation of renal epithelial function and blood pressure. In addition to research funded by the NIH and Veterans Administration, Dr. Harris is spearheading the Vanderbilt-Bayer Scientific Alliance, which has a goal of identifying and developing novel therapies for the treatment of kidney diseases. He is also co-chair of the Kidney Health Initiative, a public/private consortium sponsored by the FDA and the American Society of Nephrology, with over 100 members from industry, patient groups, physician groups and academia.
Relevant Links
VICC Profile Vanderbilt O'Brien Kidney Center
Publications
View Publications

Education

MD - Emory University, 1978

Residency - Internal Medicine - University of California, Berkeley, 1981

Fellowship - Nephrology - Brigham & Women's Hospital, 1986

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18